<DOC>
	<DOCNO>NCT00945087</DOCNO>
	<brief_summary>The primary purpose experimental therapy treat , aid bacteriophage , patient non-healing postoperative wound bone , upper respiratory tract , genital urinary tract infection extensive antibiotic therapy fail use target drug contraindicate .</brief_summary>
	<brief_title>Experimental Phage Therapy Bacterial Infections</brief_title>
	<detailed_description>Bacterial infection different tissue organ prove incurable antibiotic serious clinical problem . Bacteriophages ( phage ) bacterial virus attack , multiply within , destroy bacteria . They efficiently destroy bacteria acquire resistance antibiotic cause life-threatening infection . The method treat bacterial infection use phage know since begin 20th century . This experimental treatment enables use phage preparation rule therapeutic experiment ( basis respective Polish regulation ) case effective available therapy exist use target drug contraindicate . It research study . The bacteriophage preparation use treatment procedure contain phage Bacteriophage Collection Institute Immunology Experimental Therapy Polish Academy Sciences Wroc≈Çaw . For patient specific formulation single phage phage mixture active pathogenic bacterial strain strain isolated patient use treatment.The isolation live bacterial pathogen patient necessary carry phage-typing procedure determine preparation active formulation possible prerequisite receiving treatment .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<criteria>18 year age . Men woman reproductive age must use contraception one month therapy . Women reproductive age must negative result pregnancy test begin treatment . Signed informed consent . Antibiotic therapyresistant , chronic , symptomatic bacterial infection skin , subcutaneous tissue , bone , bone marrow , joint , fistula , wound , bedsore , genital and/or urinary tract , digestive tract , middle ear , sinus , tonsil , upper low respiratory tract , state target antibiotic therapy impossible carry due medical reason . A putative pathogenic bacteria Staphylococcus , Enterococcus , Escherichia , Citrobacter , Enterobacter , Klebsiella , Shigella , Salmonella , Serratia , Proteus , Pseudomonas , Stenotrophomonas , Acinetobacter , Burkholderia , Morganella present site say infection confirm result microbiological culture . Ineffective antibiotic therapy say infection and/or antibiogramconfirmed multidrug resistance putative pathogenic bacteria Staphylococcus , Enterococcus , Escherichia , Citrobacter , Enterobacter , Klebsiella , Shigella , Salmonella , Serratia , Proteus , Pseudomonas , Stenotrophomonas , Acinetobacter , Burkholderia , Morganella . The presence Bacteriophage Collection Institute Immunology Experimental Therapy Polish Academy Sciences phage able lyse bacterial strain culture patient Bacteriophage Collection Institute Immunology Experimental Therapy Polish Academy Sciences ( positive result phagetyping procedure ) . Pregnant breastfeed woman . Malabsorption syndrome , allergy food animal protein , advance hepatic insufficiency impossible apply phage preparation use route oral . Allergy component phage preparation . A health condition allow conduct experimental therapy opinion qualify physician .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>bacteriophage</keyword>
	<keyword>bacteriophage preparation</keyword>
	<keyword>bacterial infection</keyword>
	<keyword>antibiotic-resistant infection</keyword>
	<keyword>multidrug-resistant bacteria</keyword>
	<keyword>MRSA</keyword>
</DOC>